Nordic EMBL Partnership for Molecular Medicine
nordicembl.bsky.social
The Nordic EMBL Partnership is a major strategic player in Europe’s molecular understanding of disease mechanisms. It consists of four Nordic nodes: DANDRITE (DK), FIMM (FI), MIMS (SE) and NCMBM (NO).
👤 Joined on 20 December 2024
179
Followers
71
Following
30
Total Posts
📜 Kullanıcı Geçmişi
- 20 Ara 2024, 07:58
🎉 Bluesky'e katıldı - İlk kullanıcı adı:
@nordicembl.bsky.social
🚫 Blokladığı Kullanıcılar
❤️ Beğendiği Gönderiler
[Apply by Sept 30th] Open call for a fully funded Postdoc in our lab @dandrite.bsky.social @nordicembl.bsky.social www.nature.com/naturecareer...
Show PostOur new review article on the evolving frontier of spatial biology is now available on Current Opinion in Chemical Biology @dandrite.bsky.social @nordicembl.bsky.social @molbiolau.bsky.social: www.sciencedirect.com/science/arti...
Show Post
Meet the six new doctoral researchers who joined the FIMM-EMBL International PhD Programme this autumn, and find out what brought them here, what they hope to explore during their PhD and what they are looking forward to in the year ahead. 👇 www.helsinki.fi/en/hilife-he... @nordicembl.bsky.social
Show PostThis week, FIMM researchers have taken part in the annual meeting of the @nordicembl.bsky.social, hosted by @mimsumea.bsky.social. Many thanks to our Swedish colleagues for the warm hospitality! We also had the opportunity to meet the new @embl.org DG Anthony Hyman, whose keynote opened the meeting.
Show Post
Last week, @nordicembl.bsky.social held its annual meeting, opening with EMBL Director General Tony Hyman’s keynote. The Partnership brings together DANDRITE, FIMM, MIMS, and NCMBM and is a major strategic player in Europe's molecular understanding of disease mechanisms.
Show Post